🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Joel Charrow

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.

185 citations

Priya S. Kishnani, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Volker Straub +95 more

N/A
2.3DataRank · unranked
43 citations

Joel Charrow

Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome

American Journal of Medical Genetics Part C Seminars in Medical Genetics(2024)10.1002/ajmg.c.32095
N/A
0DataRank · unranked
3 citations

Andrea Patete, Lindsey Aschbacher‐Smith, Dima Qu’d, Geraldine Kelly‐Mancuso, Carolyn R. Raski +15 more